WiseGuyReports has announced the addition of a new business intelligence report, titled “Specialty Generics – Global Market Outlook (2016-2022)”.
Increase in prevalence of cancer across the globe and favorable government policies are the factors fueling the Global Specialty Generics market growth. Whereas factors like lack of skilled professionals is restraining the market. Oncology segment is anticipated to grow at higher CAGR during forecast period owing to the expirations of existing patent. North America accounted for the highest market share as compared to other regions owing to favorable government policies. Asia pacific region is expected to show healthy growth rate during forecast period.
Some of the key players in the market include Valeant Pharmaceuticals International, Inc., Novartis, Pfizer Inc., Turing Pharmaceuticals, Teva Pharmaceutical Ltd., Mylan N.V., Akorn, Inc., Mallinckrodt, Intellipharmaceutics and Alvogen.
Route of Administration Covered:
- Other Route of Administration
Disease Indications Covered:
- Multiple Sclerosis
- Infectious diseases
- Other Disease Indications
Distribution Channels Covered:
- Mail Order Pharmacies
- Hospital Pharmacies
- Retail Pharmacies
- North America
o Rest of Europe
- Asia Pacific
o New Zealand
o Rest of Asia Pacific
- Rest of the World
o Middle East
o South Africa
What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 6 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements
Table of Content
1 Executive Summary
3 Market Trend Analysis
4 Porters Five Force Analysis
5 Global Specialty Generics Market, By Route of Administration
6 Global Specialty Generics Market, By Disease Indication
7 Global Specialty Generics Market, By Distribution Channel
8 Global Specialty Generics Market, By Geography
9 Key Developments
10 Company Profiling
10.1 Valeant Pharmaceuticals International, Inc.
10.3 Pfizer Inc.
10.4 Turing Pharmaceuticals
10.5 Teva Pharmaceutical Ltd.
10.6 Mylan N.V.
10.7 Akorn, Inc.
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)